Cancer Family
Bone Marrow Neoplasm
CI-CAN-00000093Explore in graph →
Non-malignant1,034 active trials28 approved drugs633 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000093Explore in graph →
Clinical trials
4,612 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05832320 | Optimum Induction Therapy of Low-risk APL | unknown | N/A | 74 | Peking University People's HospitalOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03682029 | Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies(EVITA) | unknown | N/A | 109 | Rigshospitalet, DenmarkOTHER | 2 | Apr 17, 2024 | clinicaltrials |
| NCT03481868 | EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors(EPIK) | unknown | N/A | 160 | University Hospital, Clermont-FerrandOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT04663100 | Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence | unknown | N/A | 30 | University of TennesseeOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT05801835 | A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection | unknown | N/A | 36 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.INDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05926128 | Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase(AST) | unknown | N/A | 75 | FundaleuOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05734898 | NKG2D CAR-NK & r/rAML | unknown | N/A | 30 | Zhejiang UniversityOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05632874 | The Effect of Relaxing Breathing Exercise Applied to Patients Before Bone Marrow Biopsy on Vital Signs, Pain and Anxiety Levels | unknown | N/A | 72 | Uskudar UniversityOTHER | 1 | Dec 1, 2022 | clinicaltrials |
| NCT04226768 | Enhanced Palliative Care in MDS and AML | unknown | N/A | 90 | The University of Hong KongOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT04033627 | TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia | unknown | N/A | 30 | Shanghai Children's Medical CenterOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT03173612 | The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia | unknown | N/A | 132 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT05053425 | Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML | unknown | N/A | 30 | LanZhou UniversityOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT05042531 | Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia | unknown | N/A | 30 | LanZhou UniversityOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT05339204 | The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission | unknown | N/A | 75 | National Research Center for Hematology, RussiaNETWORK | 1 | Apr 21, 2022 | clinicaltrials |
| NCT05001386 | In Vitro Drug Sensitivity Testing of Fresh Human Samples(ESAAC) | unknown | N/A | 800 | Hospices Civils de LyonOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT05262465 | Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML | unknown | N/A | 300 | guomeiOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05017883 | TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Nov 4, 2021 | clinicaltrials |
| NCT05080829 | Myeloid Mutations Register in R/R CML | unknown | N/A | 29 | Grupo Cooperativo de Hemopatías MalignasOTHER | 1 | Oct 18, 2021 | clinicaltrials |
| NCT05000801 | Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia | unknown | N/A | 20 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 1 | Aug 20, 2021 | clinicaltrials |
| NCT04370457 | MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies | unknown | N/A | 300 | Centre for Research and Technology HellasOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT04920500 | Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients | unknown | N/A | 16 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.INDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT02530619 | Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia | unknown | N/A | 26 | Northwestern UniversityOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT01296178 | PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years | unknown | N/A | 200 | PETHEMA FoundationOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT04692948 | TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 | clinicaltrials |
| NCT03955848 | INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS(NKAML) | unknown | N/A | 80 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04373395 | Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML) | unknown | N/A | 65 | Zhejiang UniversityOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT04240600 | Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay(HEMVEF) | unknown | N/A | 74 | Hospital General de MexicoOTHER_GOV | 1 | Sep 3, 2020 | clinicaltrials |
| NCT04505995 | Azacitidine and Homoharringtonine in JMML | unknown | N/A | 30 | Air Force Military Medical University, ChinaOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT04168138 | D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients | unknown | N/A | 20 | Huihan WangOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT03062436 | To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission | unknown | N/A | 27 | Command Hospital, IndiaOTHER_GOV | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03902769 | Study to Assess Length of Remission With Intensive Chemotherapy in Rapidly Responding AML Patients.(AML) | unknown | N/A | 160 | Rambam Health Care CampusOTHER | 0 | Apr 8, 2019 | clinicaltrials |
| NCT03408210 | Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia | unknown | N/A | 191 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02676856 | Hematopoietic Stem Cell Microtransplantation for in AML | unknown | N/A | 40 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT03337516 | Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers | unknown | N/A | 40 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Nov 9, 2017 | clinicaltrials |
| NCT03177928 | Cardiac Changes in Myeloproliferative Neoplasms | unknown | N/A | 40 | Assiut UniversityOTHER | 0 | Jun 6, 2017 | clinicaltrials |
| NCT02863302 | Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients | unknown | N/A | 50 | Rambam Health Care CampusOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT02432872 | Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years | unknown | N/A | 300 | Jianxiang WangUNKNOWN | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02432911 | Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old | unknown | N/A | 300 | Jianxiang WangUNKNOWN | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02489929 | Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine | unknown | N/A | 35 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT01564836 | Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib | unknown | N/A | 50 | Seoul St. Mary's HospitalOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00295997 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia | unknown | N/A | 35 | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01188330 | Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival(MLSP) | unknown | N/A | 100 | Institut Paoli-CalmettesOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00462657 | Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease | unknown | N/A | 200 | St. Bartholomew's HospitalOTHER | 1 | Aug 26, 2013 | clinicaltrials |
Data updated 22 days agoSource updated May 10, 2024source: clinicaltrials